InvestorsHub Logo
Followers 466
Posts 26950
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 2150

Tuesday, 02/28/2012 9:10:45 AM

Tuesday, February 28, 2012 9:10:45 AM

Post# of 2237
7:32AM POZEN beats by $0.04, reports revs in-line (POZN) 4.47 : Reports Q4 (Dec) earnings of $2.04 per share, $0.04 better than the Capital IQ Consensus Estimate of $2.00; revenues rose 151.7% year/year to $73 mln vs the $72.91 mln consensus. Co says :2012 is an important year for POZEN. We are completing the pivotal Phase 3 studies for our leading product candidate PA32540. We expect to have the results of the studies in the second quarter and plan to file the NDA in the third quarter. We have made the decision to find a partner or partners for this and the other PA assets and, with the assistance of Keelin Reeds Partners LLC, are in discussions with potential partners. We are continuing to perform critical pre-commercialization activities required to ensure a timely launch by an eventual partner. From a financial standpoint, in 2012 we expect our R&D costs will be substantially lower due to the completion of our PA32540 Phase 3 studies and we expect our SG&A to be slightly lower year on year. Our current plan targets a year-end cash and short-term investment balance of greater than $85.0 million..


surf's up......crikey